您现在的位置是:5 q 3 4 f u w d j 5 9 j o x 8 s o c u p m h y s e k 6 p 2 > Hotspot
【zygor season of discovery】PharmaCielo Shareholder Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In PharmaCielo Ltd. To Contact The Firm
5 q 3 4 f u w d j 5 9 j o x 8 s o c u p m h y s e k 6 p 22024-09-29 12:29:45【Hotspot】1人已围观
简介New York, New York--(Newsfile Corp. - May 1, 2020) - Faruqi & Faruqi, LLP, a leading national secur zygor season of discovery
New York,zygor season of discovery New York--(Newsfile Corp. - May 1, 2020) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in PharmaCielo Ltd. (OTCQX: PCLOF) ("PharmaCielo" or the "Company") of the May 5, 2020 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
Faruqi & Faruqi logo
If you invested in PharmaCielo stock or options between June 21, 2019 and March 2, 2020
and would like to discuss your legal rights,
click here
:
www.faruqilaw.com/PCLOF
.
There is no cost or obligation to you.
You can also contact us by calling
Richard Gonnello
toll free at
877-247-4292
or at
212-983-9330
or by sending an e-mail to
.
CONTACT:
FARUQI & FARUQI, LLP
685 Third Avenue, 26
th
Floor
New York, NY 10017
Attn: Richard Gonnello, Esq.
Telephone: (877) 247-4292 or (212) 983-9330
The lawsuit has been filed in the U.S. District Court for the Central District of California on behalf of all those who purchased PharmaCielo securities between June 21, 2019 and March 2, 2020 (the "Class Period"). The case,
Daniel Gabbard v. PharmaCielo Ltd. et al
, No. 20-cv-02182 was filed on March 6, 2020, and has been assigned to Judge Philip S. Gutierrez.
The lawsuit focuses on whether the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) PharmaCielo engaged in an undisclosed related party transaction with General Extract; (2) PharmaCielo engaged in misleading transactions and loans with General Extract and XPhyto; (3) PharmaCielo's Research Technology and Processing Centre was never on-schedule and is delayed; (4) the Rionegro facility is located on a floodplain and contaminated with mold and pesticides from its previous tenants; (5) PharmaCielo's Cauca Department land has never been utilized by the Company and is idle; and (6) as a result , Defendants' public statements were materially false and/or misleading at all relevant times.
Specifically, on March 2, 2020, Hindenburg Research published a report (the "Report") explaining that PharmaCielo had failed to disclose: (1) transactions with related parties; (2) misleading business transactions and loans with General Extract and XPhyto; (3) the delayed state of its Research Technology and Processing Centre's construction; and (4) the poor state of its Rionegro Growing Facility.
On this news, PharmaCielo's stock fell from a closing price of $1.42 per share over the next two trading days to $0.9068 per share on March 3, 2020- a $0.5132 or 36.14% drop.
Story continues
The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.
Faruqi & Faruqi, LLP also encourages anyone with information regarding PharmaCielo's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (
www.faruqilaw.com
). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
To view the source version of this press release, please visit
https://www.newsfilecorp.com/release/55240
View comments
很赞哦!(67)
相关文章
- Buying a House? 4 Things to Take Off Your Must-Have List Now
- Why You Should Like Industria de Diseño Textil, S.A.’s (BME:ITX) ROCE
- BRIEF-Nanjing Red Sun Signs Framework Agreement For Industry Park Project
- Are Investors Undervaluing Groupon, Inc. (NASDAQ:GRPN) By 42%?
- GBP/USD Price Forecast – British Pound Continues to Struggle at Same Level
- LafargeHolcim completes sale of $1.75 billion Indonesian unit
- Resolutions 2019: Crush Your Debt in 3 Simple Steps
- BRIEF-Ci Resources Unit Acquires 12.9 Mln United Malacca Shares
- ICEsoft To Host Investor Call To Present Q3 Financial Results And To Provide A General Business Update
- Big Bang Theory’ Jim Parsons Believes ‘Warm’ Kaley Cuoco Will Be An ‘Incredible’ Mom
热门文章
站长推荐
Despite Its High P/E Ratio, Is Ovzon AB (publ) (STO:OVZON) Still Undervalued?
China says trade talks with U.S. made 'important progress'-Xinhua
Billboard Latin Music Conference: On the ‘Magic’ of the Zumba Fitness Craze, Its Connection to Superstars Like Don Omar
Will Nordstrom's Growth Efforts Cushion the Stock in 2019?
Pfizer-BioNTech seeks full marketing approval from UK for COVID-19 vaccine
Inflation is weak in Europe, another potential warning sign
Should You Worry About Alexanderwerk Aktiengesellschaft's (FRA:ALX) CEO Pay?
Evaluating Sartorius Aktiengesellschaft’s (FRA:SRT) Investments In Its Business
友情链接
- YUM! Brands Strategic Plans Bode Well: Should You Hold?
- Calculating The Intrinsic Value Of Avis Budget Group, Inc. (NASDAQ:CAR)
- Northwest Pipe acquires steel pipe maker Permalok
- Ripple (XRP) in Pump-and-Dump Scenario, Sinks 12% from Weekly High
- BRIEF-Nanning Sugar's Controlling Shareholder Transfers Stake In The Company To Guangxi Rural Investment
- Alibaba Is Strong Enough to Face the Regulators, Says Analyst
- CymaBay Therapeutics (NASDAQ:CBAY) Is In A Good Position To Deliver On Growth Plans
- ManpowerGroup (MAN) Q4 Earnings Beat, Revenues Miss Estimates
- UK to close all London primary schools as coronavirus cases surge
- At UK£1.43, Is Hays plc (LON:HAS) Worth Looking At Closely?